Zylox-Tonbridge, GL Capital Take 16.7% LifeTech Stake for HK$1.48B
Image
HANGZHOU – November 06, 2026 -- Zylox-Tonbridge Medical Technology (HKEX: 2190) and GL Capital will jointly invest about HK$1.482 billion in LifeTech Scientific (HKEX: 1302) for roughly 16.7% of its enlarged share capital. Zylox-Tonbridge also intends to pursue a potential merger with LifeTech.
Lighthouse Two vehicle becomes LifeTech's largest shareholder
The investment runs through GL Lighthouse Two Investment Limited, which will subscribe for newly issued LifeTech shares. On completion, Lighthouse Two becomes LifeTech's largest single shareholder. Zylox-Tonbridge holds 60% of the vehicle through an investment of about HK$889 million.
Both investors may acquire additional LifeTech shares to support closer collaboration.